Annual D&A
$1.52 M
-$3.99 M-72.40%
December 31, 2023
Summary
- As of March 11, 2025, FNCH annual depreciation & amortization is $1.52 million, with the most recent change of -$3.99 million (-72.40%) on December 31, 2023.
- During the last 3 years, FNCH annual D&A has risen by +$730.00 thousand (+92.41%).
- FNCH annual D&A is now -72.40% below its all-time high of $5.51 million, reached on December 31, 2022.
Performance
FNCH Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$44.00 K
+$1000.00+2.33%
June 30, 2024
Summary
- As of March 11, 2025, FNCH quarterly depreciation & amortization is $44.00 thousand, with the most recent change of +$1000.00 (+2.33%) on June 30, 2024.
- Over the past year, FNCH quarterly D&A has stayed the same.
- FNCH quarterly D&A is now -96.88% below its all-time high of $1.41 million, reached on December 31, 2022.
Performance
FNCH Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$183.00 K
-$13.00 K-6.63%
June 30, 2024
Summary
- As of March 11, 2025, FNCH TTM depreciation & amortization is $183.00 thousand, with the most recent change of -$13.00 thousand (-6.63%) on June 30, 2024.
- Over the past year, FNCH TTM D&A has stayed the same.
- FNCH TTM D&A is now -96.70% below its all-time high of $5.54 million, reached on March 31, 2023.
Performance
FNCH TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
FNCH Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -72.4% | 0.0% | 0.0% |
| 3 y3 years | +92.4% | 0.0% | 0.0% |
| 5 y5 years | +215.3% | 0.0% | 0.0% |
FNCH Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -72.4% | at low | -96.9% | +2.3% | -96.7% | at low |
| 5 y | 5-year | -72.4% | +215.3% | -96.9% | +2.3% | -96.7% | +13.7% |
| alltime | all time | -72.4% | +215.3% | -96.9% | +2.3% | -96.7% | +13.7% |
Finch Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | - | $44.00 K(+2.3%) | $183.00 K(-6.6%) |
| Mar 2024 | - | $43.00 K(-2.3%) | $196.00 K(-87.1%) |
| Dec 2023 | $1.52 M(-72.4%) | $44.00 K(-15.4%) | $1.52 M(-47.3%) |
| Sep 2023 | - | $52.00 K(-8.8%) | $2.88 M(-31.9%) |
| Jun 2023 | - | $57.00 K(-95.8%) | $4.24 M(-23.6%) |
| Mar 2023 | - | $1.37 M(-2.9%) | $5.54 M(+0.7%) |
| Dec 2022 | $5.51 M | $1.41 M(+0.2%) | $5.51 M(+15.3%) |
| Sep 2022 | - | $1.41 M(+3.1%) | $4.78 M(+19.1%) |
| Jun 2022 | - | $1.36 M(+2.4%) | $4.01 M(+22.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $1.33 M(+96.3%) | $3.26 M(+41.9%) |
| Dec 2021 | $2.30 M(+191.3%) | $678.00 K(+6.3%) | $2.30 M(+25.1%) |
| Sep 2021 | - | $638.00 K(+3.4%) | $1.84 M(+30.8%) |
| Jun 2021 | - | $617.00 K(+67.7%) | $1.41 M(+41.0%) |
| Mar 2021 | - | $368.00 K(+70.4%) | $997.00 K(+26.2%) |
| Dec 2020 | $790.00 K(+63.9%) | $216.00 K(+5.4%) | $790.00 K(+37.6%) |
| Sep 2020 | - | $205.00 K(-1.4%) | $574.00 K(+55.6%) |
| Jun 2020 | - | $208.00 K(+29.2%) | $369.00 K(+129.2%) |
| Mar 2020 | - | $161.00 K | $161.00 K |
| Dec 2019 | $482.00 K | - | - |
FAQ
- What is Finch Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Finch Therapeutics?
- What is Finch Therapeutics annual D&A year-on-year change?
- What is Finch Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Finch Therapeutics?
- What is Finch Therapeutics quarterly D&A year-on-year change?
- What is Finch Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Finch Therapeutics?
- What is Finch Therapeutics TTM D&A year-on-year change?
What is Finch Therapeutics annual depreciation & amortization?
The current annual D&A of FNCH is $1.52 M
What is the all time high annual D&A for Finch Therapeutics?
Finch Therapeutics all-time high annual depreciation & amortization is $5.51 M
What is Finch Therapeutics annual D&A year-on-year change?
Over the past year, FNCH annual depreciation & amortization has changed by -$3.99 M (-72.40%)
What is Finch Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of FNCH is $44.00 K
What is the all time high quarterly D&A for Finch Therapeutics?
Finch Therapeutics all-time high quarterly depreciation & amortization is $1.41 M
What is Finch Therapeutics quarterly D&A year-on-year change?
Over the past year, FNCH quarterly depreciation & amortization has changed by $0.00 (0.00%)
What is Finch Therapeutics TTM depreciation & amortization?
The current TTM D&A of FNCH is $183.00 K
What is the all time high TTM D&A for Finch Therapeutics?
Finch Therapeutics all-time high TTM depreciation & amortization is $5.54 M
What is Finch Therapeutics TTM D&A year-on-year change?
Over the past year, FNCH TTM depreciation & amortization has changed by $0.00 (0.00%)